Ben Zvi Lior, Maman David, Margulis Michael, Berkovich Yaron
Department of Orthopedics, Carmel Medical Center, Haifa 3436212, Israel.
Rappaport Faculty of Medicine, Israel Institute of Technology, Haifa 2611001, Israel.
Int J Environ Res Public Health. 2025 Sep 5;22(9):1387. doi: 10.3390/ijerph22091387.
Diabetic foot ulcers (DFUs) affect approximately 15% of diabetic patients and are the leading cause of non-traumatic lower extremity amputations worldwide. This study examines trends in DFU management, predictors of major amputation and in-hospital mortality, and the impact of comorbidities on outcomes.
Using the Nationwide Inpatient Sample (NIS) database (2016-2019), we analyzed non-elective admissions of DFU patients categorized into four treatment groups: no surgery, debridement, minor amputation, and major amputation (below-knee or above-knee). Statistical analyses identified factors associated with major amputation and mortality.
A significant increase in minor amputations and debridement was observed between 2016 and 2019, while the number of major amputations declined ( < 0.001). Comorbidities varied significantly by treatment type, with dyslipidemia (49.4-51.0%), chronic kidney disease (30.1-44.2%), and hypertension (32.9-47.0%) being the most prevalent ( < 0.001). Major amputation was associated with the highest rate of in-hospital mortality (1.00%) and the longest hospital stay (11.2 days) ( < 0.001). Logistic regression identified sepsis (OR = 4.9, 95% CI: 4.3-5.6), stroke (OR = 3, 95% CI: 2.1-5.5), and pulmonary embolism (OR = 3.7, 95% CI: 2-6) as key predictors of major amputation, while myocardial infarction (OR = 956, 95% CI: 319-2857) and sepsis (OR = 25, 95% CI: 20-29) were the strongest predictors of mortality ( < 0.001).
These findings underscore the impact of comorbidities on DFU outcomes and emphasize the need for early intervention to reduce severe complications. Future research should focus on optimizing management strategies for high-risk patients to improve clinical and surgical outcomes.
糖尿病足溃疡(DFU)影响约15%的糖尿病患者,是全球非创伤性下肢截肢的主要原因。本研究探讨了DFU治疗趋势、大截肢和住院死亡率的预测因素,以及合并症对治疗结果的影响。
利用全国住院患者样本(NIS)数据库(2016 - 2019年),我们分析了DFU患者的非择期住院情况,这些患者被分为四个治疗组:未手术、清创、小截肢和大截肢(膝下或膝上)。统计分析确定了与大截肢和死亡率相关的因素。
2016年至2019年间,小截肢和清创显著增加,而大截肢数量下降(<0.001)。合并症因治疗类型而异,血脂异常(49.4 - 51.0%)、慢性肾病(30.1 - 44.2%)和高血压(32.9 - 47.0%)最为常见(<0.001)。大截肢与最高的住院死亡率(1.00%)和最长的住院时间(11.2天)相关(<0.001)。逻辑回归确定败血症(OR = 4.9,95%CI:4.3 - 5.6)、中风(OR = 3,95%CI:2.1 - 5.5)和肺栓塞(OR = 3.7,95%CI:2 - 6)是大截肢的关键预测因素,而心肌梗死(OR = 956,95%CI:319 - 2857)和败血症(OR = 25,95%CI:20 - 29)是死亡率的最强预测因素(<0.001)。
这些发现强调了合并症对DFU治疗结果的影响,并强调了早期干预以减少严重并发症的必要性。未来的研究应侧重于优化高危患者的管理策略,以改善临床和手术结果。